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Abstract
Asp fI is a major allergen/antigen/cytotoxin of Aspergillus fumigatus and exhibits ribonuclease activity. This allergen plays a
role in allergic and invasive Aspergillosis and reported as a major cytotoxin with ribonuclease activity. To express the protein
in large quantity and to characterize the multifunctional nature of Asp fI, we have generated recombinant baculovirus by intro-
ducing the gene in pFastBac HTa expression vector and expressed in insect cell. The baculovirus expression vector system has
been used as a versatile system for the efficient expression of proteins with most eukaryotic posttranslational modification.
Recombinant Asp fI was expressed as ~1% of the total cellular protein in infected Sf9 insect cells. The protein was purified
using Ni2+ affinity column chromatography and the yield of purified protein was ~10 mg/1 g of total cellular protein. Immuno-
reactivity of the protein was determined by immunoblot analysis using both poly His monoclonal antibody, IgG and IgE anti-
bodies present in the sera of ABPA patients. The protein was glycosylated as revealed by the glycoprotein staining and was
observed to retain both ribonuclease and cytotoxic activities. These results suggest that Asp fI expressed in insect cell was post
translationally modified and biologically active that can be used as a diagnostic marker for biochemical studies. (Mol Cell
Biochem 252: 157–163, 2003)
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Introduction
Asp fI is a multifunctional protein secreted by A. fumigatus
and implicated in pathogenesis of Aspergillus related disor-
ders. It is a Concanavalin A (ConA) non-binding allergen in-
ducing type I and III hypersensitivity reactions in allergic
form of aspergillosis [1]. Asp fI was reported as a ribotoxin
and it has structural and functional similarities with α-sarcin,
mitogillin and restrictocin, which are ribotoxin secreted by the
nonpathogenic strains of Aspergillus species [2–6]. These tox-
ins hydrolyze the 28S rRNA and inhibit protein synthesis lead-
ing to cytotoxicity in eukaryotic cells [1–4]. Few cytotoxic
ribonucleases are glycoproteins and their glycan moieties are
important for internalization or transmembrane localization of
the toxin [7].
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However, recent observation on binding of Asp fI towards
lung surfactant proteins SP-A and SP-D which has structural
homology with C1q lectin suggests presence of carbohydrate
moieties on the surface of the protein. Several groups have
studied the interaction of lung surfactant protein SP-A and SP-
D with glycosylated antigen/allergens of A. fumigatus, which
inhibit specific IgE binding and block the histamine release
from sensitized basophils [8, 9]. In another study it has been
shown SP-A and SP-D bind to the glycosyl moieties of the
allergens (45 and 55 kDa) of A. fumigatus and inhibit specific
IgE binding to the allergens [9, 10]. Inhibition of IgE binding
activity of Asp fI was also observed in presence of lung sur-
factant protein suggests the involvement of carbohydrate
moiety in immunological activities of the protein (thesis sub-
mitted 1999 to University of Delhi by Priyadarsiny et al.).
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Moreover a number of immunodominant glycoprotein al-
lergens and antigens of A. fumigatus are glycoproteins with
catalytic activities. [9–11]. The biochemical functions of these
proteins may contribute to the pathogenesis of the disease.
The recombinant Asp fI expressed in prokaryotic systems
didn’t elaborate on the biological activity such as ribonucle-
ase activity and cytotoxicity. Expressed recombinant Asp fI
showed 50% reduced ribonuclease activity and specific cy-
totoxic activity was absent compare to the native protein
which could be due to the lack of post translational modifi-
cation in the protein expressed in E. coli [13].
To address these problems, in the current report we ex-
pressed Asp fI protein in insect cells using recombinant
baculovirus expression system. Expressed recombinant Asp
fI was purified by single step purification method using Ni2+
affinity chromatography. Protein was characterized for the
post translational modification and immunological activity.
Purified protein showed specific binding to IgG and IgE an-
tibody present in the sera of ABPA patients. The protein re-
tained its ribonuclease activity and was toxic to the mouse
macrophages similar to that of native Asp fI. High level ex-
pression of biologically active rAsp fI in Sf9 insect cells sug-
gest that in this system Asp fI protein can be generated as a
heterologous source which can be used in diagnostics and for
structure function studies.
Materials and methods
Genomic DNA purification, PCR amplification and
cloning of Asp fI gene
Briefly, the genomic DNA was isolated from the mycelial
extract of 4-day-old A. fumigatus cultures (strain no. 2605
from the patients sputum cultured at V. P. Chest institute,
Delhi [14]. Asp fI gene was PCR amplified from the genomic
DNA of A. fumigatus and initially cloned in TA-cloning vec-
tor (Clontech). DNA isolated from the positive clone was fur-
ther PCR amplified with PP1[GCA AAG CTT GCG ACC TGG
ACA TGT ATA AAC CAG CAG] and PP2 primers [CGG GAT
CCC TAA TGA GAA CAC AGT CTC AA] to incorporate
Bam HI restriction site after stop codon. Amplified DNA was
treated with Klenow polymerase to make blunt ends and puri-
fied using phenol-chloroform extraction followed by ethanol
precipitation. Purified DNA was digested with EcoRI and the
gel extracted to subclone in pFastbac HTa vector (BRL Life
Technology) digested with EcoRI – Stu I and recombinant
baculovirus construct is designated as pFastBac HTa-AspfI.
The Asp fI gene was sequenced using PP2 and M13 forward
primers in a dideoxy chain termination Cycle Sequencing kit
(Amersham) and proper reading frame was verified before
use in expression studies. Asp fI bacmid was generated by
homologous recombination of pFastBac HTa-Asp fI plasmid
with the bacmid DNA present in DH10 Bac competent cells.
Transformation and screening of positive clones were per-
formed according the protocol suggested by the manufacturer
(BRL Life Technology).
Expression and purification of recombinant Asp fI
Sf9 insect cells were maintained in SFM (ATCC) containing
5 µg/ml streptomycin and 5 U/ml penicillin at 27°C. Cells in
a six-well plate was transfected by using CELL FECTIN rea-
gents (Life Technologies) at 80% cell confluency. In brief:
5–10 µg of bacmid DNA diluted in 100 ul of Opti-MEM was
mixed with 20 µl of CELL FECTIN diluted in equal volume
of Opti-MEM. The mixture was incubated at room tempera-
ture for 45 min. The transfection cocktail was diluted further
upto 1 ml in Opti-MEM before layered on Sf9 cells and in-
cubated for 5 h at 27°C. After the incubation transfection
cocktail was substituted with the SFM till it was harvested
after 72 h post transfection and characterized for the expres-
sion of recombinant protein.
Sf9 insect cells were transfected at 0.1 multiplicity of in-
fection (MOI) for the expression of the recombinant Asp fI
protein. After 72 h post infection cells were harvested and re-
suspended in PBS. The cells were centrifuged at 500 × g for
5 min to get rid of serum PBS and pellet was resuspended in
lysis buffer (50 mM Tris-HCl pH 8.5, 10 mM 2 mercapto-
ethanol, 1 mM PMSF, 1% NP-40 at 4°C). Insoluble debris
was removed by centrifugation at 10,000 × for 10 min and
the cell supernatant was diluted in Buffer A (20 mM Tris HCl,
pH 8.5, 500 mM KCl, 10 mM 2-mercaptoethanol, 10% gly-
cerol) to incubate with equilibrated Ni2+ resin. Protein bound
resins were packed in a column at 4°C and washed exten-
sively using 5–10 vol. of wash buffer (20 mM Tris pH 8.0,
500 mM KCl, 20 mM imidazole, 10 mM 2 mercaptoethanol,
10% glycerol) in a flow rate of 0.5 ml/min. The column was
re-equilibrated with 10 vol. buffer A and the bound protein was
eluted with 5–10 vol. of Buffer B (20 mM Tris HCl pH 8.5,
100 mM KCl, 0–50 mM imidazole, 10 mM 2-mercaptoethanol,
10% glycerol. Eluted fractions (0.5 ml) were collected in sepa-
rate tubes and analyzed the protein by SDS PAGE.
SDS-PAGE and immunoblot
Proteins were separated on 15% denaturing gel by SDS-PAGE
[15] and transferred to the nitrocellulose membrane (Schleicher
& Schell, 0.45 µ pore size) as described by Towbin [16]. The
membrane was blocked for 1 h in PBS containing 3% non-
fat milk at room temperature and incubated with poly-His
(1:1000 dilution) or anti-Asp fI (1:100 dilution) monoclonal
antibody for 3 h at 37°C. Membrane was washed in PBS-
0.1% Triton X-100 solution and incubated for 2 h with anti
159
mouse IgG peroxidase (1:2000 dilution in PBS). Finally the
membrane was washed in PBS–0.1% Triton X-100 solution







Purified recombinant Asp fI protein was analysed on the SDS-
PAGE and stained for glycoprotein using the silver staining
method [17]. The sample was electrophoresed on SDS-PAGE
gel and fixed overnight in 200 ml of solution containing 25%
isopropanol and 7% acetic acid. The gel was incubated with
oxidizing solution (1.05 g of periodic acid in 150 ml of dis-
tilled water + 4 ml of 25% isopropanol in 7% acetic acid) for
5 min followed by extensive washing with distilled water. The
gel was incubated for 10 min with silver nitrate staining solu-
tion (28 ml of 0.1 N NaOH, 1 ml of ammonium hydroxide, 5
ml of 20% silver nitrate and 115 ml of distilled water) and
developed with the developing solution (50 mg of citric acid,
0.5 ml of formaldehyde (37%) in 1 litre of distilled water). Fi-
nally 0.35% acetic acid was added to the gel for neutralization.
Toxicity assay
Murine macrophage cells (Raw264.7, J774) were maintained
in DMEM containing 10% FCS, 100 µg/ml streptomycin and
100 U penicillin at 37°C with 5% CO
2
. Equal numbers of cells
were cultured in a 96-well plate for cytotoxicity assay. Vary-
ing concentrations of Asp fI protein, purified from A. fumi-
gatus as well as purified rAsp fI expressed in insect cells were
diluted in DMEM and added in triplicate to the cultured cells
[18]. Cytolysis was monitored after 8 h by MTT assay. In
brief: 1.5 mg/ml MTT was added to the culture media and
the cells were incubated for 30 min. Then the culture media
was substituted with 100 µl of acidified isopropanol solution
per well to lyse the cells. The absorbance of the supernatant
was measured at 570 nm and analyzed as percent cell viable
to that of the control (without any protein treatment) [18].
Ribonuclease activity
Different concentrations of Asp fI (0.1–1µg) were incubated
with 1% yeast RNA in 0.1M acetate buffer, pH 5.0 for 3 h at
37°C. After 3 h, RNA was precipitated with 0.5 ml of 75%
uranyl acetate in 25% of perchloric acid at 4°C. The reaction
mixture was centrifuged at 13,000 rpm for 10 min and su-
pernatant containing soluble nucleotides was measured at
A
260
. One unit of ribonuclease is defined as the amount of
protein required to produce a δ A
260
 of 1.0 of acid soluble
nucleotides when incubated with 1% substrate RNA for 15
min at pH 7.4 in a reaction volume of 1.5 ml.
Results and discussion
Cloning expression and purification of Asp fI gene in
insect Sf9 cells
Asp fI gene spans 450 bp in the fungal genome and the tran-
script encodes a protein of ~18 kDa consisting 149 amino
acids. PCR amplified Asp fI gene was cloned down stream
of polyhedrin promoter in EcoRI and StuI sites of pFastBac
HTa transfer plasmid. Recombinant bacmid was generated
by site-specific recombination between transfer plasmid
pFastBac HTa containing Asp fI and bacmid in host E. coli
(DH10 BAC). Sf 9 cells infected with recombinant baculo-
virus was analyzed for expression of Asp fI. Analysis of the
insect cell proteins expressing Asp fI comprise ~1% of the
total cellular protein determined by densitometric analysis of
protein band.
For large-scale purification, Sf9 cells were infected with
the recombinant baculovirus at 5 MOI. Insect cells were lysed
to release the expressed protein in the supernatant. Recom-
binant protein with poly-HIS tag was bound to Ni2+ affinity
resins and eluted with the buffer containing 20 mM Imida-
zole. Our previous attempt to express Asp fI in E. coli resulted
insoluble protein, localized in the inclusion bodies. Lack of
post-translational modification necessary for proper folding
and solubility of the Asp fI protein could be responsible for
producing insoluble protein in E. coli. Since prokaryotic
expression hosts lack the machinery for post translational
modification such as glycosylation, phosphorylation neces-
sary for proper folding and solubility of the eukaryotic pro-
teins, insect cell (baculovirus expression system) was used
to study the expression of Asp fI. Recombinant rAsp fI was
expressed in Sf9 insect cells and soluble protein purified by
affinity chromatography was analysed by 15% SDS-PAGE.
Coomassie blue stained gel showed a major 18 kDa homog-
enous protein band in the lane containing whole insect cell
lysate infected with baculovirus (Fig. 1). Molecular weight
of rAsp fI (18 kDa) was similar to native Asp fI (purified from
synthetic culture of A. fumigatus) but higher than the protein
expressed in E. coli [5, 13]. Such discrepancy in the molecular
weight of the rAsp fI could be the result of post translational
modification in the protein.
Immunological activity of rAsp fI
rAsp fI immunologically specific to IgG and IgE present in
the ABPA patients
The specificity of the purified Asp fI was analysed in the
Western blot analysis using poly-His monoclonal antibody.
A protein band of 18 kDa was detected in the Western blot
probed with poly-HIS monoclonal antibody (Fig. 2). Mono-
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clonal antibody used was specific to the poly-His (hexa-histi-
dine) tag confirming the expressed protein is a fusion protein
with histidine tag and matched with the expected molecular
weight (18 kDa) as has been observed with native Asp fI
protein.
Asp fI is a major antigen/allergen that binds specifically
to the IgG and IgE antibodies present in the serum of ABPA
patients [1, 3]. Several groups have also identified the epi-
topic region of Asp fI which demonstrated distinct IgE anti-
body binding response against sera from ABPA patients and
proliferative responses in peripheral blood mononuclear cells
from the patients [19, 20].
To determine if the baculovirus expressed rAsp fI retains
the identical immunoreactivity with the IgG and IgE antibody
of the ABPA patients, immunoblot of rAsp fI was treated with
ABPA patient’s sera. Baculovirus expressed rAsp fI exhibited
specific binding to both IgG and IgE antibodies present in the
patient’s serum similar to native Asp fI (Fig. 3). The results
suggest that the protein retains its antigenicity and allergenicity
comparable to the native fungal Asp fI protein. The purified
recombinant antigen rAsp fI can be used for screening the
serum of ABPA patients and for immunodiagnosis of aspergil-
losis.
rAsp fI, a Glycoprotein
To characterize the post-translational protein modification of
rAsp fI, the purified protein was subjected to glycoprotein
staining [17]. The rAsp fI migrated as an 18 kDa protein band
stained positive in glycoprotein staining (Fig. 4). This finding
substantiates our earlier observation that native Asp fI inter-
acts with different lectins such as GNA, PNA, MAA, SNA and
DSA (data not shown). Baculovirus expression system is
Fig. 2. Western blot analysis of rAsp fI against poly-histidine monoclonal
antibody. Lane 1 – protein molecular weight markers; lane 2 – purified rAsp
fI expressed in Sf9 cell.
Fig. 1. SDS-PAGE analysis of rAsp fI expressed in Sf9 insect cell trans-
fected with recombinant bacmid. Lane 1 – purified rAsp fI; lane 2 – ex-
pressed rAsp fI in cell lysate of Sf 9 cell; lane 3 – native Asp fI.
known to produce necessary glycosylation in the protein. It
is worth mentioning that sometimes hyper-glycosylation oc-
curs through baculovirus expression system that helps to
identify potential glycosylation domains in the protein. In
case of rAsp fI hyperglycosylation could not be the case since
the expressed protein has a molecular weight identical to the
native protein expressed in A. fumigatus.
Some of the glycoproteins ranging from 20–90 kDa are
characterized as allergens secreted by A. fumigatus [21–23].
Carbohydrate moieties of many fungal and plant glycopro-
teins have been shown to be responsible for specific IgE bind-
ing activity. Recent report on Asp f2 protein of A. fumigatus
showed specific binding of Asp f2 to IgE antibodies in the
sera of ABPA patients. Comparison of amino acid sequence
of Asp f2 showed homology with a 37 kDa ConA nonbind-
ing protein with possible glycosylation sites [11, 12]. The
Figure 3. Immunoblot analysis of rAsp fI using pooled serum of ABPA
patients. Membrane strips immobilized with purified rAsp fI were detected
for specific immunoglobulin binding by Western blot analysis. Lane 1, IgG
antibody; lane 2, IgE antibody.
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allergenic proteins, gp45 and gp55 of A. fumigatus have been
characterized as N-linked glycoproteins and deglycosylation
abolishes their binding to IgE in the ABPA patient’s serum
[21–23]. The IgE binding of these allergens was inhibited in
presence of SP-A and SP-D, which bind through their car-
bohydrate recognition domains suggesting that SP-A and SP-
D may be involved in the modulation of allergic sensitization
[8, 9]. The IgE binding activity of Asp fI was also significantly
inhibited in presence of lung surfactant protein .The role of
carbohydrate moieties in the immunological activities of the
protein needs to be investigated.
Ribonuclease activity of rAsp fI
Asp fI exhibited ribonuclease activity in in vitro experiments
[2, 4]. Similar studies were carried out to determine the ri-
bonuclease activity of rAsp fI purified from the insect cell.
The degradation pattern of the yeast RNA incubated with
native and rAsp fI are identical (data not shown). The spe-
cific activity of rAsp fI was determined as 102 kunitz/mg in
comparison to 108 kunitz/mg in case of native Asp fI (Table
1). The purified rAsp fI produced enhanced ribonuclease ac-
tivity than the crude insect cell lysate containing rAsp fI. This
observation suggests that the activity is specific to the puri-
fied protein. Control buffers do not produce any activity (data
not shown). The ribonuclease activity observed in case of the
rAsp fI was comparable to that of native Asp fI and bovine
RNase A protein. Earlier reports on recombinant Asp fI pro-
tein in E. coli showed only 50% ribonuclease activity com-
pared to the activity of native protein [13]. These results
suggest a possible role of carbohydrate moiety in the ribo-
nuclease activity of rAsp fI.
Glycosylation appears to contribute natural conformation
and ribonuclease activity of the Asp fI protein. The functional
domain of Asp fI is primarily dependent on specific amino
acid residues like His, Cys, Glu, which are generally involved
in the RNase mechanism [4]. Native Asp fI and α-sarcin pro-
duce a fragment of 400 bp RNA by the specific cleavage of
28S rRNA [2–4]. However, the catalytic domain in Asp fI is
not yet identified.
Cytotoxicity assay of rAsp fI
Native Asp fI is toxic to mouse macrophage cells. Cytotoxic
activity of purified rAsp fI was studied in an identical assay
system and compared with that of native Asp fI, purified
from the fungus (Fig. 5). Cytotoxic activity of rAsp fI in-
creased in a dose dependent manner at a concentration range
of 125–1000 ng/ml for both J774A.1 and RAW264.7 mouse
macrophages. IC
50 
of the purified rAsp fI was found to be
250 ng while IC
50 
of the native Asp fI is 80 ng/ml. However,
Asp fI expressed in insect cells did not produce any cyto-
toxic effect to the host insect cells. Though the mechanism
of Asp fI internalization and specific substrate for ribonu-
clease activity in the cell is still not known, it is hypothesized
that the mechanism may be similar to α−sarcin, which binds
preferentially to negative charge inducing phospholipid
Fig. 4. Carbohydrate staining of rAsp fI. Lane 1 – protein molecular weight
marker; lane 2 – Purified rAsp fI protein.
Table 1. Ribonuclease activity of native and purified recombinant Asp fI
protein
Units of ribonuclease activity (kunitz/mg)
Native 18 kDa 108
Purified rAsp fI 102
rAsp fI in Sf9 cell lysate 86
Ribonuclease A 96
Fig. 5. Cytotoxic activity of rAsp fI on macrophages (RAW 264.7). Crude
cell extract represented as heavy dots and purified rAsp fI are represented
as light dots in the toxicity graph.
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aggregation and fusion of lipid vesicles for the internaliza-
tion [2].
Presence of ribonuclease activity of rAsp fI suggests the
inhibition of protein synthesis by hydrolysing the phospho-
diester bond of 28S rRNA similar to the native Asp fI. It has
been reported that some of the ribotoxins enter into the cell by
endocytosis [24]. After vesicular transport, the toxin crosses
an intracellular membrane in order to reach its substrate.
Molecular modeling studies of restrictocin suggest ability of
RNase to cross the cell membrane through a loop, which is
similar to lectin sugar binding domain [25]. As Asp fI has
sequence homology with restrictocin, analysis of secondary
structure of Asp fI could give some important clue for the
catalytic sites involved in the function.
Asp fI, a multifunctional glycoprotein secreted from the
pathogenic species of Aspergillus is structurally and func-
tionally similar to ribotoxin of a non-pathogenic species of
Aspergillus genus. Asp fI could play a dual role in the patho-
genesis of A. fumigatus related disorders (a) by promoting
fungal colonization through cytotoxic activity (b) inducing
inflammatory reaction involving IgE antibodies present on
human lung mast cell [26].
Current study was undertaken with a view to examine the
role of glycosylation in the biological activities of Asp fI,
which is a con A non-binding immunodominant protein. Pres-
ence of ribonuclease and cytotoxic activity of rAsp fI indi-
cated that post translational modification might play a role
in its biological function. In view of the multifunctional na-
ture of this allergen, site directed mutagenesis can be used to
identify immunodominant region of the molecule which could
help in delineating the functional domain of the allergen ri-
bonuclease and identify the pockets in the secondary struc-
ture responsible for its biological function. Current work
opens up the scope of using this Aspergillus allergen as a
model for understanding the structure-function relationship
of the pathogen related proteins and the mechanism involved
in the pathogenesis of Aspergillosis.
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